Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-26-008792·CITADEL ADVISORS LLC
Schedule 13G ownership disclosure
PLIANT THERAPEUTICS INC
Common Stock, par value $0.0001 per share (the "Shares") · CUSIP: 729139105
Event date: 2026-01-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Citadel Advisors LLC
Shares: 2,099,798.00 · Class: 3.4%
- Citadel Advisors Holdings LP
Shares: 2,099,798.00 · Class: 3.4%
- Citadel GP LLC
Shares: 2,099,798.00 · Class: 3.4%
- Citadel Securities LLC
Shares: 909,171.00 · Class: 1.5%
- Citadel Securities Group LP
Shares: 937,897.00 · Class: 1.5%
- Citadel Securities GP LLC
Shares: 937,897.00 · Class: 1.5%
- Kenneth Griffin
Shares: 3,037,695.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-008792
- Form type
- SCHEDULE 13G
- Filer
- CITADEL ADVISORS LLC
- CIK
- CIK 1423053
- Filed
- Jan 30, 2026
- Reporting period
- Jan 23, 2026
- Description
- Schedule 13G beneficial ownership